Egypt: Rameda's OGM nods to bonus shares distribution

Reuters Images

Rameda is an Egypt-based pharmaceutical company that manufactures both human and veterinary pharmaceuticals

Staff Writer, Arab Finance

April 10, 2023

PHOTO

Tenth of Ramadan for Pharmaceuticals Industries and Diagnostic Reagents’s (Rameda) ordinary general meeting (OGM) has approved disbursing 0.50726-for-1 bonus shares worth a total of EGP 127.89 million to shareholders, the company stated on April 10th.

Hence, the company’s issued capital shall increase to EGP 380 million distributed over 1.52 billion shares at a nominal value of EGP 0.25 per share.

It is worth noting that the company posted a consolidated net profit attributable to the parent company of EGP 245.676 million in 2022, compared to EGP 181.088 million in 2021.

Rameda is an Egypt-based pharmaceutical company that manufactures both human and veterinary pharmaceuticals.

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.

ZAWYA NEWSLETTERS

RELATED ARTICLES

ZAWYA NEWSLETTERS

LATEST VIDEO